Flossbach Von Storch Ag Bio N Tech Se Put Options Transaction History
Flossbach Von Storch Ag
- $22.7 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.5MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$831 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$434 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$192 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$183 Million1.03% of portfolio
-
Capital International Investors Los Angeles, CA1.42MShares$143 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...